Item 8.01. Other Events.

On December 6, 2020, Global Blood Therapeutics, Inc. issued two press releases titled "GBT Presents New Data on the Long-Term and Real-World Use of Oxbryta® (voxelotor) Tablets in Patients with Sickle Cell Disease at 62nd ASH Annual Meeting and Exposition" and "GBT Presents Data on New Sickle Cell Disease Pipeline Therapies with Best-in-Class Potential - Inclacumab and GBT021601." Copies of the press releases are attached as Exhibits 99.1 and 99.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits

Exhibit No.    Description

                 Press Release, dated December 6, 2020, titled "GBT Presents New
  99.1         Data on the Long-Term and Real-World Use of Oxbryta® (voxelotor)
               Tablets in Patients with Sickle Cell Disease at 62nd ASH Annual
               Meeting and Exposition"
                 Press Release, dated December 6, 2020, titled "GBT Presents Data
  99.2         on New Sickle Cell Disease Pipeline Therapies with Best-in-Class
               Potential - Inclacumab and GBT021601"
104            Cover Page Interactive Data File (embedded within Inline XBRL
               document)

© Edgar Online, source Glimpses